The latest buy for my Special Situations portfolio is Ryman Hospitality (NYSE: RHP ) . The company operates four of the top 10 largest convention hotels in the U.S., and it converted to a REIT late last year, making it more likely to trade for a higher multiple. In March, I bought $2,000 of the stock, and it has since done little but go down. But Ryman is a solid company with premier properties that deserves to trade at a premium to peers, rather than a steep discount. So I'm adding another $1,000 to my position.
A brief recap
In my original write-up, I pointed out why you should love Ryman:
Why it's cheap now
The stock traded to the mid-$40s following its conversion, but since then, the stock has been hit by a few different winds:
Best Low Price Stocks To Watch For 2015: Nuvilex Inc (NVLX.PK)
Nuvilex, Inc., incorporated on October 28, 1996, operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation. It is focused on preparations for a new pancreatic cancer clinical trial through live-cell encapsulation of chemotherapeutic-converting cells. It has created the hardware and operating platform to envelop or encapsulate its own or other company's software products, or cells. These cells are then packaged in its live cell encapsulation operating system. Its products include Cinnechol, Cinnergen, Cinnsational, Citroxin, Cyclosurface, Cosmetics, Infinitink, Talsyn, Oraphyte and PurEffect. On July 10, 2013, the Company acquired Bio Blue Bird AG. In November 2013, the Company announced that it has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the development of treatments for diabetes from SG Austria Pt e. Ltd.
Cinnechol
Cinnechol is a gluten free/wheat free all-natural supplement designed to help maintain normal cholesterol levels and support normal cardiovascular function through a healthy diet and regular exercise and to help individuals manage cardiovascular and metabolic disorders. Cinnechol may provide a natural alternative for those with high cholesterol and intolerant of, or elect not to take statins.
Cinnergen
Cinnergen is a gluten free/wheat free all-natural liquid whole food nutritional supplement that provides nutrients to help the body efficiently process glucose, is made from natural ingredients. Clinical studies using Cinnergen, as well as peer reviewed research suggest constituents of Cinnergen may help to reduce glucose absorption in the small intestine, limit glucose synthesis and increase its metabolism and prevent conditions associated with pre-diabetes or diabetes types one and two by delivering amin o acids, vitamins, minerals, enzymes, antioxidants, and pl! an! t based extracts to the body thus helping control glucose levels.
Cinnsational
Cinnsational is a gluten free/wheat free all-natural calorie-free, liquid nutritional supplement contains concentrated blend vitamins, essential amino acids, and other beneficial ingredients to help the body combat symptoms associated with alcohol sensitivity, including nausea, fatigue and headaches.
Citroxin
Citroxin is an all-natural, eco-friendly surface cleaner. Citroxin is protected by patents in the United States and Thailand.
Cyclosurface Cosmetics
Nuvilex�� Cyclosurface color enhancement technology provides formulators and manufacturers of cosmetics and other consumer products the ability to use less wax and other potentially detrimental additives in their products through a lipophilic surface treatment. It improves pigment dispersion enabling products that feel lighter on the skin and make the skin look radia nt while maintaining or enhancing the color and durability of the cosmetic product.
I-Boost Immune Bar
I-Boost Immune Bar is a gluten free/wheat free all-natural nutritional bar designed to protect, stimulate, and boost the immune system. It was reformulated and contains a blend of vitamins, minerals, and other ingredients designed to enhance the body's natural ability to defend itself.
Infinitink
Infinitink is a permanent, yet removable tattoo ink, was engineered specifically for removal in fewer laser treatments than standard tattoo ink. Typically, lasers used for removal of tattoos use 532 and 1064 nanometer wavelengths which closely match the Infinitink tattoo pigments, enabling more easily removed tattoos.
Oraphyte
Oraphyte is the Company�� all-natural nematocide, is a non-toxic, biodegradable formulation that damages a nematode's skin surface, compromising its immune system, enabling it to be killed by the environment. In field tests, Oraphyte! redu! ce! d probl! ematic nematodes, parasitic plant worms found in soil, compared to non-treated controls.
purEffect
PurEffect is a three part, all-in-one acne treatment designed to cleanse, tone, and heal skin combining ingredients to help maintain a radiant, blemish-free complexion. Benzoyl peroxide, the active ingredient in purEffect is the safest, recommended ingredient used to treat acne. This line of products completed pre-marketing testing by CK41.
Specialty, Private Label Inks
The Company has the potential to manufacture specialty inks for private label customers derived from the Company's Virgin and Infinitink product lines and are formulated to specific customer needs. The Company's specialty inks are formulated to be all natural, heavy metal and toxin-free.
Talsyn Scar Cream
Talsyn Scar Cream is a cream that delivers lipids, peptides, and botanical extracts to the skin. It was clinically proven to impro ve appearance of keloids, surgical incisions, and scars through decreasing their width, length, depth, and redness for both old and new scars. Talsyn Scar Cream has been endorsed and used by plastic and reconstructive surgeons.
Advisors' Opinion:- [By Alan Brochstein]
I actually spoke with Mr. Tim Matula, who is a former director and also handled investor relations for Diamond Ranch Foods (the predecessor company). Mr. Matula is also a long-time director at Nuvilex (NVLX.PK), which I recently suggested is an overly promoted stock exhibiting several of the signs about which FINRA has been warning investors (more on this later). Matula answered the phone number included on recent press releases by PLPL - I was expecting to hear an answering machine, as my call was in the late evening. He explained that he was no longer involved with the company due to having too many time-constraints. He also explained his sale of 4.9mm shares back to the company at $0.025 on February 7th, suggesting an open market sale would have been impossible. Note that PLPL has never traded below $0.04, so I found this curious. It was Matula who passed me along to Shane Traveller. He also told me that he is the brother of Tom Matula, the Chairman of the Scientific Advisory Board (more later).
Top 10 High Dividend Companies To Buy Right Now: EZCORP Inc.(EZPW)
EZCORP, Inc. provides specialty consumer financial services. The company offers pawn loans that are non-recourse loans collateralized by tangible personal property, including jewelry, consumer electronics, tools, sporting goods, and musical instruments, as well as sells merchandise consisting of second-hand collateral forfeited from its pawn lending activities or purchased from customers, and new or refurbished merchandise from third party vendors. It also provides a range of financial services, such as signature loans consisting of payday loans, installment loans, and lines of credit; and auto title loans, which include single payment auto title loans, and auto title lines of credit. In addition, the company offers fee-based credit services to customers seeking loans; and advice and assistance to customers in obtaining loans from unaffiliated lenders, as well as provides debit cards. As of September 30, 2011, it operated a total of 1,111 locations consisting of 433 pawn s tores under the EZPAWN or Value Pawn names, and 436 financial services stores under the EZMONEY name in the United States; 178 pawn stores under the Empe� F�il or Empe� Su Oro names in Mexico; 49 financial services stores under the CASHMAX name in Canada; and 15 financial and retail services stores under the Cash Converters name in Canada. Further, the company operates as a franchisor for 13 franchised Cash Converters stores in Canada. EZCORP, Inc. was founded in 1989 and is headquartered in Austin, Texas.
Advisors' Opinion:- [By Ben Levisohn]
Shares of World Acceptance Corporation have plunged 19% to $79.19 at 3:43 p.m.–and dragged down anything remotely connected to payday lending. Cash America International (CSH) has dropped 7.8% to $39.35, pawn-shop operator EZCorp (EZPW) has fallen 3.7% to $12.33, and wire-transfer companies Western Union (WU) and MoneyGram International (MGI) have fallen 2.6% and 5.8%, respectively.
Top 10 High Dividend Companies To Buy Right Now: Elan Corporation PLC (ELN)
Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.
Tysabri
Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.
In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.
Beta Amyloid Immunotherapies (AIP)
Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).
ELND005, an A� Aggregation Inhibitor
The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.
Neotope Biosciences Limited
Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.
Onclave Therapeutics Limited
Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.
The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.
Advisors' Opinion:- [By Brian Orelli]
Johnson & Johnson (NYSE: JNJ ) is the leader for the long-acting antipsychotic, selling $1.4 billion worth of Risperdal Consta and $800 million worth of Invega Sustenna last year. Alkermes (NASDAQ: ALKS ) also benefits from a royalty on both drugs. It developed the extended-release technology in Risperdal Consta, and Alkermes acquired the royalty rights to Invega Sustenna when it bought Elan's (NYSE: ELN ) drug technology division.
- [By Sofia Horta e Costa]
Bellway Plc (BWY) added 1.4 percent after the homebuilder said reservations in the past four months rose 31 percent as buyers had greater access to mortgages. Elan (ELN) Corp. jumped to a 10-month high in Dublin after Royalty Pharma increased its offer for the Irish drugmaker to as much as $6.7 billion. BT Group increased 3.7 percent as Barclays Plc recommended investors buy shares of the U.K.�� largest fixed-line company.
Top 10 High Dividend Companies To Buy Right Now: UniSource Energy Corporation(UNS)
UniSource Energy Corporation engages in the electric generation and energy delivery businesses. The company?s TEP segment generates, transmits, and distributes electricity to approximately 403,000 retail electric customers, including residential, commercial, industrial, and public sector customers in southeastern Arizona. It also sells electricity to other utilities and power marketing entities. As of December 31, 2010, this segment owned or leased 2,245 MW of net generating capacity, as well as owned or participated in electric transmission and distribution system consisting of 512 circuit-miles of 500-kV lines; 1,087 circuit-miles of 345-kV lines; 379 circuit-miles of 138-kV lines; 478 circuit-miles of 46-kV lines; and 2,621 circuit-miles of lower voltage primary lines. TEP segment generates electricity from coal, gas, oil, and solar sources. The company?s UNS Gas segment distributes gas to approximately 146,500 retail customers in Mohave, Yavapai, Coconino, and Navajo c ounties in northern Arizona, as well as Santa Cruz County in southeastern Arizona. As of December 31, 2010, this segment?s transmission and distribution system consisted of approximately 30 miles of steel transmission mains, 4,211 miles of steel and plastic distribution piping, and 136,439 customer service lines. The company?s UNS Electric segment transmits and distributes electricity to approximately 91,000 retail customers consisting of residential, commercial, and industrial customers in Mohave and Santa Cruz counties. As of December 31, 2010, UNS Electric?s transmission and distribution system consisted of approximately 56 circuit-miles of 115-kV transmission lines, 271 circuit-miles of 69-kV transmission lines, and 3,599 circuit-miles of underground and overhead distribution lines. This segment also owns the 65 MW Valencia plant, as well as 39 substations having an installed capacity of 1,788,050 kilovolt amperes. The company was founded in 1902 and is based in Tucson, Arizona.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
UNS Energy (NYSE: UNS) shot up 27.75 percent to $58.56 after the company agreed to be acquired by Fortis Utility Group for $60.25 per share in cash. - [By David Dittman]
And with its December 2013 offer to buy Arizona-based UNS Energy Corp (NYSE: UNS) for $2.5 billion in cash St. John’s, Newfoundland and Labrador-based Fortis Inc (TSX: FTS, OTC: FRTSF), making its second foray in the US in two years, signaled its interest in regulated utility assets in states with favorable population and economic trends as a means of driving its growth going forward.
Top 10 High Dividend Companies To Buy Right Now: Surge Energy Inc (ZPTAF.PK)
Surge Energy Inc. is an oil focused exploration and production (E&P) company. The Company has projects in Southern Saskatchewan/the Williston Basin, SE Alberta and Valhalla/Nipisi. In January 2014, Surge Energy Inc. announced the SE Saskatchewan light oil acquisition. Advisors' Opinion:- [By Value Digger]
In late January 2013, I wrote an article about Surge Energy (ZPTAF.PK), an oil-weighted intermediate producer with operations in Canada and US. It was when the price dropped below $4. Actually, I recommended Surge Energy back then at $3.7, for the reasons mentioned here.
Top 10 High Dividend Companies To Buy Right Now: U.S. Geothermal Inc. (HTM)
U.S. Geothermal, Inc. engages in the acquisition, development, and utilization of geothermal resources in the western region of the United States. It constructs and manages power plants that utilize geothermal resources to produce energy. The company operates two power plants, including the Raft River geothermal power project located in the Raft River area of southern Idaho; and a 3.6 MW operating geothermal power plant and approximately 30,734.21 acres of geothermal energy leases and certain ground water rights located north of Reno, Nevada. It also holds interests in the Neal Hot Springs project located in eastern Oregon, which is under construction; Raft River project with 10 parcels comprising 783.93 acres of fee land and 4,736.79 acres of contiguous leased geothermal rights located on private property in Cassia County, Idaho; and lease contracts for approximately 21,905 acres of land and geothermal rights located in the San Emidio Desert, Nevada. In addition, the comp any has a geothermal lease contract for Granite Creek assets comprising approximately 2,443 acres of land and geothermal water rights located in the northwestern Nevada; and owns a geothermal concession consisting of 24,710 acres located southwest of Guatemala City, the Republic of Guatemala. Further, it has a joint venture agreement for geothermal rights for 3,615 acres located in northwestern Nevada. U.S. Geothermal, Inc. was founded in 2002 and is based in Boise, Idaho.
Advisors' Opinion:- [By Bryan Murphy]
By most accounts, it's an all-American dream come true. U.S. Geothermal Inc. (NYSEMKT:HTM), working hard - for years - to make something out of nothing can finally see the light at the end of the tunnel. HTM has swung to a profit, and is strong enough now that it's probably going to remain in the black in perpetuity. Shareholders who got into U.S. Geothermal anytime during or after 2012 have finally been handsomely rewarded, with most of that reward materializing in just the past three weeks. Regardless of when an investor got into a position in HTM though, there's just one thing left to do at this point.... get out. Lock in your gain and walk away, at least for a little while.
- [By Bryan Murphy]
It's fun to be right, particularly when it has to do with stock-picking. Sometimes though, being right can be a real pain in the @#$%. Case in point? U.S. Geothermal Inc. (NYSEMKT:HTM). It was only two days ago that yours truly deemed HTM was a good-looking "buy" for true long-termers. Then today happens... a 27% rally that should have wise investors - even those who stepped into U.S. Geothermal with a long-term mindset - at least thinking about locking in their profits and walking away with a quick score. After all, you can always buy HTM back later.
Top 10 High Dividend Companies To Buy Right Now: PDC Energy Inc (PDCE)
PDC Energy, Inc. (PDC), incorporated on March 25, 1955, doing business as PDC Energy, is a domestic independent exploration and production company, which acquires, develops, explores, and produces natural gas, natural gas liquids (NGLs), and crude oil. Its Western Operating Region is focused on development in the Wattenberg Field in Colorado, particularly in the liquid-rich horizontal Niobrara play and on the ongoing development of refractures and recompletions of its Wattenberg wells. In its Eastern Operating Region, it is focused on development activity in the liquid-rich portion of the Utica Shale play in Ohio. The Company owns an interest in approximately 7,200 gross producing wells and maintained an average production rate of 135.6 One million cubic feet of natural gas volume (MMcfe) per day for the year ended December 31, 2012, which was comprised of 65.3% natural gas, 10.2% NGLs and 24.5% crude oil. It divides its operating activities into two segments: Oil and Gas Exploration and Production, and Gas Marketing. It divides its Western Operating Region into two areas: the Wattenberg Field and Piceance Basin. On February 28, 2012, the Company divested its Permian Basin assets. In May 2012, it announced that it has executed a definitive agreement to acquire Core Wattenberg assets that contain liquid-rich horizontal drilling opportunities. The effective date of the transaction is April 1, 2012. The assets are located in the Core Wattenberg Field of Weld and Adams Counties, Colorado and are approximately 94%-operated. The acquired assets include an estimated 35,000 net acres prospective for horizontal development of the Niobrara and Codell formations. In July 2012, the Company acquired core Wattenberg assets. In September 2012, Miller Energy Resources, Inc. acquired its Tennessee assets. On June 18, 2013, PDC Energy Inc announced that it has sold its non-core Colorado natural gas assets.
Oil and Gas Exploration and Production
The Company�� Oil and Gas Exploration and Prod! uction segment reflects revenues and expenses from the production and sale of natural gas, NGLs and crude oil. It sells its natural gas to marketers, utilities, industrial end-users and other wholesale purchasers. It sells natural gas, which it produces under contracts with indexed or New York Mercantile Exchange (NYMEX) monthly pricing provisions with the remaining production sold under contracts with daily pricing provisions. Its contracts include provisions wherein prices change monthly with changes in the market, for which adjustments may be made based on whether a well delivers to a gathering or transmission line, quality of natural gas and prevailing supply and demand conditions. It does not refine any of its crude oil production. It sells its crude oil to oil marketers and refiners. Its crude oil production is sold to purchasers at or near its wells under both short and long-term purchase contracts with monthly pricing provisions based on an average daily price. Its NGLs are sold to one NGL marketer in the Wattenberg Field. Its NGL production is sold under both short and long-term purchase contracts with monthly pricing provisions based on an average daily price.
The Company�� Oil and Gas Exploration and Production segment also reflects revenues and expenses related to well operations and pipeline services. It is paid a monthly operating fee for the portion of each well it operates that is owned by others, including its affiliated partnerships. It constructs, owns and operates gathering systems in its areas of operations. Its natural gas and NGLs are transported through its own and third party gathering systems and pipelines. It enters into firm transportation agreements to provide for pipeline capacity to flow and sell a portion PDC Energy, Inc. (PDC), incorporated on March 25, 1955, doing business as PDC Energy, is a domestic independent exploration and production company, which acquires, develops, explores, and produces natural gas, natural gas liquids (NGLs), and crude oil. Its! Western ! Operating Region is focused on development in the Wattenberg Field in Colorado, particularly in the liquid-rich horizontal Niobrara play and on the ongoing development of refractures and recompletions of its Wattenberg wells. In its Eastern Operating Region, it is focused on development activity in the liquid-rich portion of the Utica Shale play in Ohio. The Company owns an interest in approximately 7,200 gross producing wells and maintained an average production rate of 135.6 One million cubic feet of natural gas volume (MMcfe) per day for the year ended December 31, 2012, which was comprised of 65.3% natural gas, 10.2% NGLs and 24.5% crude oil. It divides its operating activities into two segments: Oil and Gas Exploration and Production, and Gas Marketing. It divides its Western Operating Region into two areas: the Wattenberg Field and Piceance Basin. On February 28, 2012, the Company divested its Permian Basin assets. In May 2012, it announced that it has executed a definitive agreement to acquire Core Wattenberg assets that contain liquid-rich horizontal drilling opportunities. The effective date of the transaction is April 1, 2012. The assets are located in the Core Wattenberg Field of Weld and Adams Counties, Colorado and are approximately 94%-operated. The acquired assets include an estimated 35,000 net acres prospective for horizontal development of the Niobrara and Codell formations. In July 2012, the Company acquired core Wattenberg assets. In September 2012, Miller Energy Resources, Inc. acquired its Tennessee assets.
Oil and Gas Exploration and Production
The Company�� Oil and Gas Exploration and Production segment reflects revenues and expenses from the production and sale of natural gas, NGLs and crude oil. It sells its natural gas to marketers, utilities, industrial end-users and other wholesale purchasers. It sells natural gas, which it produces under contracts with indexed or New York Mercantile Exchange (NYMEX) monthly pricing provisions with the remaining p! roduction! sold under contracts with daily pricing provisions. Its contracts include provisions wherein prices change monthly with changes in the market, for which adjustments may be made based on whether a well delivers to a gathering or transmission line, quality of natural gas and prevailing supply and demand conditions. It does not refine any of its crude oil production. It sells its crude oil to oil marketers and refiners. Its crude oil production is sold to purchasers at or near its wells under both short and long-term purchase contracts with monthly pricing provisions based on an average daily price. Its NGLs are sold to one NGL marketer in the Wattenberg Field. Its NGL production is sold under both short and long-term purchase contracts with monthly pricing provisions based on an average daily price.
The Company�� Oil and Gas Exploration and Production segment also reflects revenues and expenses related to well operations and pipeline services. It is paid a monthly operating fee for the portion of each well it operates that is owned by others, including its affiliated partnerships. It constructs, owns and operates gathering systems in its areas of operations. Its natural gas and NGLs are transported through its own and third party gathering systems and pipelines. It enters into firm transportation agreements to provide for pipeline capacity to flow and sell a portion
Advisors' Opinion:- [By Seth Jayson]
PDC Energy (Nasdaq: PDCE ) reported earnings on May 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), PDC Energy whiffed on revenues and beat expectations on earnings per share.
No comments:
Post a Comment